
A daytime neuromuscular electrical stimulation device that strengthens tongue muscles to reduce snoring and mild obstructive sleep apnea.
ExciteOSA is an FDA-cleared daytime therapy device for mild obstructive sleep apnea and snoring. Unlike treatments worn during sleep, ExciteOSA is used for 20 minutes daily while awake. The device delivers electrical stimulation to tongue muscles through a mouthpiece, strengthening and toning them over time. This improved muscle function helps keep the airway open during sleep. It represents a new category of OSA treatment based on neuromuscular training.
The device's mouthpiece contains electrodes that deliver mild electrical stimulation to the tongue during therapy sessions. This stimulation exercises the genioglossus and other tongue muscles, improving their endurance and tone. Stronger tongue muscles are better able to maintain airway patency during sleep, reducing the collapse that causes snoring and mild apnea events.
ExciteOSA is indicated for adults with mild obstructive sleep apnea (AHI 5-15) or primary snoring who want a non-invasive, daytime treatment option. It may be particularly appealing to those who prefer not to wear devices during sleep or who have trouble with CPAP or oral appliances.
Unlike CPAP or oral appliances, ExciteOSA is used during the day, leaving sleep unencumbered by devices.
No surgery, no implants, no devices worn during sleep. Just 20 minutes of daily training.
Simple mouthpiece design with app-guided therapy sessions. Can be done while watching TV or relaxing.
For patients who've struggled with other treatments, ExciteOSA offers a fundamentally different approach.
Clinical studies show significant reduction in snoring, benefiting patients and bed partners.
Most side effects are minor and can often be resolved with simple adjustments.
ExciteOSA is only indicated for mild OSA. Patients with moderate or severe OSA need more aggressive treatment.
Benefits require consistent daily use. Missing sessions may reduce effectiveness.
The electrical stimulation creates a tingling or pulsing sensation in the tongue, which some find uncomfortable.
Benefits develop over weeks of consistent use. Not an immediate solution.
As a newer treatment, long-term effectiveness data is still being gathered.
The current commercially available device with mouthpiece and control unit.
Standard protocol involves 20-minute daily sessions for 6 weeks, then maintenance schedule.
Get a sleep study to confirm mild OSA (AHI 5-15) or primary snoring. ExciteOSA isn't appropriate for moderate-severe OSA.
Consistent daily use is essential. Build the 20-minute session into your daily routine.
Begin with lower stimulation levels and increase as you become comfortable with the sensation.
Use the app to track sessions and, if available, objective measures of snoring to see improvement.
Expect to use the device for several weeks before noticing significant improvement in snoring or sleep quality.
A follow-up sleep study after completing the initial treatment course can verify improvement.